Intelligent Bio Solutions Inc. (NASDAQ: INBS)
Intelligent Bio Solutions Inc. (NASDAQ: INBS)

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Overview

Contact top employees from Intelligent Bio Solutions Inc. (NASDA...

Summary

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a public company that has been in the industry for 31 years. The company currently specializes in the Medical Devices, Health Care Equipment, Health Care Technology areas. The position of the President & CEO is occupied by Harry Simeonidis. Its headquarters is located at New York, New York, USA. The number of employees ranges from 100 to 250. The annual revenue of Intelligent Bio Solutions Inc. (NASDAQ: INBS) varies between 100K and 5.0M. Total funding of the company - $25M. To connect with Intelligent Bio Solutions Inc. (NASDAQ: INBS) employee register on SignalHire.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) industries

Medical Devices

Headquarters Location

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Employees Size

100-200 employees

Specialties

drug testing kits, workplace drug testing, fingerprint drug screening, non-invasive drug test, health and safety, safety, drug test confirmation, accessible testing solutions, portable drug testing, Intelligent Fingerprinting Drug Testing, Complete Drug Testing Solution, drug screening, drug testing, fingerprint drug test

DMA Code

New York Metropolitan Area

Founded

2017

Estimated Annual Revenue

$100K - 5.0M

Operating Status

Independent Company

Contact Intelligent Bio Solutions Inc. (NASDAQ: INBS)

Organization Website

Social Links

linkedInlinkedIntwitter

Phone Number

1-212-546-7876

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Competitors

Founded
Type
Employees
Revenue
Funding
1996Public
Company
1.0K - 5.0K 2B $32.6M
1888Public
Company
100K - 9.9M 40.2B $6.9M
1976Privately
Held
100 - 250 26.2M $0
2009Privately
Held
25 - 100 5.7M $0
2002Privately
Held
50K - 100K 51.1B $0
1995Privately
Held
1.0K - 5.0K 50M $0
2008- 10-50 - $-
1896- 10000+ - $-

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Revenue

Annual Revenue
< 1M
Revenue dynamics are not stable. Minor drop in revenue in Q1 2020 was replaced by slight growth in Q4 2020. Revenue then showed a significant drop again in Q1 2021. As a result, the company's quarterly revenue increased by 35.1K - from -798.0 in Q4 2019 to 34.3K in Q1 2021.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Employees Turnover 2 quarter 2025

Contact top employees from Intelligent Bio Solutions Inc. (NASDA...
Derek Mapoli
Project Manager Capital assets
View Email & Phone
Jules Kappes
Head Of Business Operations
View Email & Phone
Anna Turkington
Vice President of Marketing
View Email & Phone
Rafael da Luz
Vice President of Global Regulatory Affairs
View Email & Phone
Harry Simeonidis
President and CEO IBS Inc
View Email & Phone
Daniel Brown
Head of Clinical Affairs
View Email & Phone
Taylor Doherty
Brand & Marketing Manager
View Email & Phone
AL ALFAAZ
Management Executive
View Email & Phone
Derek Mapoli
Head of Project Management
View Email & Phone
Michelle Talarico
Growth Strategy Marketing Manager
View Email & Phone
Spiro Sakiris
Chief Financial Officer
View Email & Phone
BACK TO TOP